Dow Jumps Over 500 Points; US Consumer Sentiment Declines In October

Market Performance - U.S. stocks experienced a positive trading session, with the Dow Jones index increasing by more than 500 points, closing up 1.19% at 47,289.61. The NASDAQ rose 1.27% to 23,232.48, and the S&P 500 gained 0.98% to 6,804.28 [1] - Communication services sector saw a rise of 1.2%, while energy stocks declined by 0.4% [1] Economic Indicators - The University of Michigan consumer sentiment index was revised down to 53.6 in October from a preliminary reading of 55 and compared to 55.1 in September [2][11] - The S&P Global services PMI increased to 55.2 in October from 54.2 in the previous month, exceeding market expectations of 53.5 [11] - The S&P Global manufacturing PMI rose to 52.2 in October from 52.0, also surpassing estimates of 52.0 [11] - The S&P Global composite PMI jumped to 54.8 in October from 53.9 in September [11] - Year-ahead inflation expectations in the U.S. decreased to 4.6% in October from 4.7% in September [11] Commodity Prices - Oil prices increased by 0.7% to $62.19, while gold prices decreased by 0.1% to $4,143.10. Silver fell by 0.4% to $48.530, and copper dropped by 0.2% to $5.0985 [5] International Markets - European shares were mostly higher, with the eurozone's STOXX 600 rising by 0.07%. Spain's IBEX 35 gained 0.15%, London's FTSE 100 rose by 0.32%, Germany's DAX 40 increased by 0.14%, while France's CAC 40 fell by 0.30% [6] - Asian markets closed mostly higher, with Japan's Nikkei 225 gaining 1.35%, Hong Kong's Hang Seng index up by 0.74%, and China's Shanghai Composite rising by 0.71%. India's BSE Sensex, however, fell by 0.41% [7] Company News - Wellgistics Health, Inc. shares surged by 229% to $1.3501 after signing a non-binding letter of intent with Datavault AI Inc. to integrate blockchain technology [9] - Genenta Science S.p.A. shares increased by 108% to $6.81 following an expanded collaboration with ANEMOCYTE [9] - Inhibrx Biosciences, Inc. shares rose by 74% to $49.26 after positive trial results for Ozekibart in chondrosarcoma [9] - Deckers Outdoor Corporation shares fell by 13% to $89.00 after reporting second-quarter results that missed revenue estimates [9] - MultiSensor AI Holdings, Inc. shares dropped by 46% to $0.7340 due to a $14 million private placement announcement [9] - MaxLinear, Inc. shares decreased by 13% to $15.31 following third-quarter results [9]